Showing 16,401 - 16,420 results of 16,577 for search '(( 50 ppm decrease ) OR ( 50 ((((a decrease) OR (we decrease))) OR (nn decrease)) ))', query time: 0.56s Refine Results
  1. 16401

    DataSheet_1_Metabolome and transcriptome association analysis revealed key factors involved in melatonin mediated cadmium-stress tolerance in cotton.docx by Ling Li (38566)

    Published 2022
    “…The results showed that the cotton seedlings were dwarfed and the leaves were wilted and yellow under Cd stress. The application of 50 µmol L<sup>−1</sup> MT significantly increased the superoxide dismutase (SOD) activity and malondialdehyde (MDA) content under Cd stress, but 100 µmol L<sup>−1</sup> MT significantly decreased SOD activity, while increased ascorbate peroxidase (APX) activity significantly. …”
  2. 16402

    Dupilumab improves sense of smell and clinical outcomes in patients with severe chronic rhinosinusitis with nasal polyps with anosmia by Andrew P. Lane (20367704)

    Published 2024
    “…<p>Loss of sense of smell is a cardinal symptom of chronic rhinosinusitis with nasal polyps (CRSwNP) and significantly impacts health-related quality-of-life. …”
  3. 16403

    Table_1_Effects of dietary Chinese yam polysaccharide copper complex on growth performance, immunity, and antioxidant capacity of broilers.docx by Jinzhou Zhang (386968)

    Published 2023
    “…A total of 360 1-day-old 817 broiler chickens were randomly divided into 4 groups, with 3 replicates of 30 birds each and were fed a basal diet with the addition of 0 (control group), 0.02, 0.10, and 0.50 g/kg CYP-Cu. …”
  4. 16404

    Table_1_Clinical features, immunologic parameter and treatment outcome of Chinese tuberculosis patients with or without DM.DOCX by Fengjun Tong (18809563)

    Published 2024
    “…Background<p>The coexistence of diabetes mellitus (DM) and pulmonary tuberculosis (PTB) poses a significant health concern globally, with their convergence presenting a considerable challenge to healthcare systems. …”
  5. 16405

    Image_1_Formation and Transfer of Multi-Species Biofilms Containing E. coli O103:H2 on Food Contact Surfaces to Beef.JPEG by Yuchen Nan (318766)

    Published 2022
    “…O103:H2 single-species biofilms served as a control positive (T4). Coupons were stored dry (20–50% relative humidity; RH) or moist (60–90% RH) for up to 60 days, at which point O103:H2 transfer to beef and survival was evaluated. …”
  6. 16406

    Table_1_Formation and Transfer of Multi-Species Biofilms Containing E. coli O103:H2 on Food Contact Surfaces to Beef.DOCX by Yuchen Nan (318766)

    Published 2022
    “…O103:H2 single-species biofilms served as a control positive (T4). Coupons were stored dry (20–50% relative humidity; RH) or moist (60–90% RH) for up to 60 days, at which point O103:H2 transfer to beef and survival was evaluated. …”
  7. 16407

    Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  8. 16408

    Supplementary file 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  9. 16409

    Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  10. 16410

    Table 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  11. 16411

    USUV replicates in STAT1-sufficient peripheral tissues leading to spleen and liver pathology. by Amy N. Nelson (21763146)

    Published 2025
    “…<b>(H)</b> Immunostaining of liver tissue harvested from a <i>Stat1</i><sup>-/-</sup> mouse using the histiocyte marker CD68, anti-JEV NS3 to mark USUV infection, and DAPI with a 50 µm scale bar. …”
  12. 16412

    Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  13. 16413

    Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  14. 16414

    Supplementary file 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  15. 16415

    Table_2_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.DOCX by Harshit Singh (6724346)

    Published 2019
    “…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
  16. 16416

    Table_1_Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.DOCX by Harshit Singh (6724346)

    Published 2019
    “…Compared to baseline, TSA treatment increased mRNA levels of P-gp and MRP-1 (fold change 7.51, 7.31, <sup>*</sup>p < 0.0001 in SRNS) and (fold change 3.49, 3.35, <sup>*</sup>p < 0.0001 in SSNS), respectively. It significantly decreased the level of HDAC2 (fold change 1.50, <sup>*</sup>p < 0.0001 in SRNS) (fold change 2.53, <sup>*</sup>p < 0.0001 in SSNS) patients.…”
  17. 16417

    Species- and life-stage-specific thermosensory behaviors and thermal physiology. by Ben T. Gregory (20442502)

    Published 2024
    “…<i>elegans</i> adults display a noxious heat escape response and have a very decreased lifespan, brood size, and hatching viability [<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012529#pntd.0012529.ref034" target="_blank">34</a>,<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012529#pntd.0012529.ref037" target="_blank">37</a>–<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012529#pntd.0012529.ref039" target="_blank">39</a>,<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012529#pntd.0012529.ref042" target="_blank">42</a>,<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012529#pntd.0012529.ref043" target="_blank">43</a>,<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012529#pntd.0012529.ref050" target="_blank">50</a>,<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0012529#pntd.0012529.ref069" target="_blank">69</a>].…”
  18. 16418

    Figure 5 from KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma by Elisabet Figuerola-Bou (22618659)

    Published 2025
    “…<p>KDM6A KO decreases Ewing sarcoma tumor growth. <b>A,</b> Colony formation assay of KDM6A KO cells (sgRNA#1 and sgRNA#2) compared with parental cells and sgCTRL in A-673. …”
  19. 16419

    TcdB3 has reduced binding to CSPG4. by Zhenrui Pan (10047214)

    Published 2021
    “…The percentage of rounded cells were plotted over toxin concentrations. Their CR50 were measured and plotted in a bar chart (I). …”
  20. 16420

    Table_2_“Longitudinal Fecal Microbiome Study of Total Body Irradiated Mice Treated With Radiation Mitigators Identifies Bacterial Associations With Survival”.xlsx by Kelvin Li (158276)

    Published 2021
    “…Survival improved relative to control (30.0%) for G-CSF (80%, p-value = 0.025), G-CSF/JP4-039 (70%, p-value = 0.084), but not for JP4-039 (50.0%). In the second experiment, mice were administered mitigation drugs “inhibiting programmed cell death” pathways: JP4-039 (anti-apoptosis), necrostatin-1 (anti-necroptosis), and baicalein (anti-ferroptosis), in eight combinations. …”